Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia
نویسندگان
چکیده
منابع مشابه
Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia.
BACKGROUND Lanthanum carbonate is a non-calcium phosphate binder that is effective for the treatment of hyperphosphatemia. However, it is unknown whether treatment with lanthanum affects survival. METHODS We retrospectively collected data on maintenance hemodialysis patients at 22 facilities (n = 2292) beginning in December 2008, a time point immediately prior to the commercial availability o...
متن کاملEfficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding
Lanthanum carbonate (LaC) is a non-calcium-based phosphate binder used to treat hyperphosphatemia in patients with chronic kidney disease. Oral administration of LaC is difficult in patients undergoing tube feeding or those who are of advanced age because it is essential to chew the LaC tablet sufficiently before swallowing it. We report two cases in whom crushed LaC was used in hemodialysis pa...
متن کاملPharmacoeconomic Analysis: Analysis Of Cost-Effectiveness Of Lanthanum-Carbonate (Lc) In Uncontrolled Hyperphosphatemia In Dialysis.
reached the therapeutic target set by the K/DOQI Guidelines (P< 5.5 mg/dL). The economic evaluation was conducted according to the hospital perspective and were considered the only consumption associated with the purchase of the drugs administered. Results: The combination of LC plus standard therapy has produced a significant increase in the percentage of patients who achieved the target range...
متن کاملManagement of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate
Elevated serum phosphate levels as a consequence of chronic kidney disease (CKD) contribute to the increased cardiovascular risk observed in dialysis patients. Protein restriction and dialysis fail to adequately prevent hyperphosphatemia, and in general treatment with oral phosphate binding agents is necessary in patients with advanced CKD. Phosphate plays a pivotal role in the development of v...
متن کاملcomparing the effects of nicotinic acid and carbonate lanthanum on hyperphosphatemia in the hemodialysis patients: a double-blind clinical trial
background: control of the phosphorus in hemodialysis patients is very important and can be done in many ways. the purpose of the study was to compare the effects of nicotinic acid and lanthanum carbonate on hyperphosphatemia in the hemodialysis patients. materials and methods: this double-blind randomized clinical trial was done in imam hossein hospital (shahroud, iran) in 2014. the participan...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2014
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/gfu335